Unlock stock picks and a broker-level newsfeed that powers Wall Street.

3 ASX Penny Stocks With Market Caps Over A$9M To Consider

In This Article:

The Australian market has recently experienced a slight downturn, with the ASX200 down 0.35% at 8240 points, largely due to declines in commodity prices affecting mining stocks. Amidst these fluctuations, investors often look towards penny stocks as a potential avenue for growth, particularly those that combine lower price points with strong financial fundamentals. While the term "penny stock" might seem outdated, it continues to highlight opportunities within smaller or newer companies that can offer significant value and growth potential despite broader market challenges.

Top 10 Penny Stocks In Australia

Name

Share Price

Market Cap

Financial Health Rating

Embark Early Education (ASX:EVO)

A$0.76

A$139.45M

★★★★☆☆

Helloworld Travel (ASX:HLO)

A$1.88

A$306.1M

★★★★★★

Austin Engineering (ASX:ANG)

A$0.545

A$337.98M

★★★★★☆

SHAPE Australia (ASX:SHA)

A$2.72

A$225.52M

★★★★★★

LaserBond (ASX:LBL)

A$0.62

A$72.68M

★★★★★★

MaxiPARTS (ASX:MXI)

A$1.87

A$103.44M

★★★★★★

Navigator Global Investments (ASX:NGI)

A$1.60

A$784.13M

★★★★★☆

EZZ Life Science Holdings (ASX:EZZ)

A$2.94

A$130.6M

★★★★★★

Perenti (ASX:PRN)

A$1.165

A$1.08B

★★★★★★

Big River Industries (ASX:BRI)

A$1.34

A$114.39M

★★★★★☆

Click here to see the full list of 1,035 stocks from our ASX Penny Stocks screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Energy Transition Minerals

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Energy Transition Minerals Ltd engages in mineral exploration and evaluation activities in Australia, with a market cap of A$33.81 million.

Operations: The company generates revenue from its Mineral Exploration and Evaluation segment, amounting to A$0.049 million.

Market Cap: A$33.81M

Energy Transition Minerals Ltd, with a market cap of A$33.81 million, is currently pre-revenue and unprofitable, reporting a net loss of A$2.39 million for the half year ended June 30, 2024. Despite this, the company has no debt and maintains a solid cash position with short-term assets of A$16.3 million exceeding both its short- and long-term liabilities. The management team and board are relatively new with average tenures of less than two years, which may impact strategic continuity. Shareholder dilution has not been significant recently, providing some stability in ownership structure amidst ongoing challenges in profitability growth.

ASX:ETM Debt to Equity History and Analysis as at Nov 2024
ASX:ETM Debt to Equity History and Analysis as at Nov 2024

Patrys

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Patrys Limited, with a market cap of A$9.26 million, develops and commercializes antibody technologies for cancer treatment in Australia.